Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Review which Dividend Aristocrats ETF has the highest management fee and how it affects net performance.
28,021 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Outpoll launches a global prediction market platform, bringing professional tools and API access to a mainstream audi...
Silver prices climb in 2026, lifting pure-play silver miners trading below $30. Investors weigh the appeal of physica...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
When a professional advisor exits a stake in TREX, it can signal shifts in strategy or risk controls. This guide brea...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
Regulators weigh new crypto rules as quantum risk looms in 2026. CryptoQuant founder Ki Young Ju’s idea to freeze dor...
Freedom Superior LLC will acquire Seneca Mortgage Servicing LLC to broaden its MSR capabilities, signaling a strategi...
JPMorgan Chief Executive Jamie Dimon hints at a post-CEO second act that could include writing, teaching, and media p...
Apollo-owned Michaels is reshaping its business by absorbing assets from rival bankruptcies, expanding party and fabr...